参考文献
[1] Kawano S， Horikawa M， Yasohara Y， et al.Microbial enantios－elective reduction of aeetylpyridine derivatiyes[J]．Biosci.Biotech－nol.Biochem.， 2003， 67 （4 ） :809-815． [2] Holland H L.Organic Synthesis Oxidative Enzyme [M].VCHPublishers： New York， 1992.41
[3] 周德庆.微生物学教程[M].北京： 高等教育出版社， 1993， 11.
[4] Ball P．Biocatalysis： synthesis methods that exploit enzymaticactivities[J]. Nature， 2001， 409 （6818 ） :225.
[5] Schoemaker H， Mink D， Wubbolts M． Dispelling the myths- bioca-talysis in industrial synthesis ［J］． Science，2003，299(5613):1694. [6] 孙志浩． 生物催化制备手性化合物技术进展［J］． 精细与专用化学品, 2006(24):5. [7] Schmid A， Dordick J， Hauer B， et al． Industrial biocatalysis todayand tomorrow[J]. Nature， 2001， 409(6817):258.
[8] Agrawal Y， Bhatt H， Raval H， et al． Chirality- a new era of thera-peutics[J]. Mini reviews in medicinal chemistry， 2007， 7(5):451.
[9] Armstrong D， Gasper M， Lee S， et al． Factors controlling the leveland determination of D- amino acids in the urine and plasma oflaboratory rodents[J].． Amino Acids， 1993， 5(2):299. [10] 陈绍怡， 杨秀， 秦玉静． 手性药物合成中的生物转化[J]..生物工程进展， 2000， (04):60.
[11] Brocks D． Drug disposition in three dimensions:an update on
stereoselectivity in pharmacokinetics[J]. Biopharmaceutics ＆drug disposition， 2006， 27(8):387.
[12] 孙志浩. 手性技术与生物催化[J]. 生物加工过程, 2004,(04):6. [13] Salgin U，Salgin S，Taka S．The enantioselective hydrolysis of racemic naproxen methyl ester insupercritical co2 using Candidarugosa lipase[J]．The Journal of Supercritical Fluids，2007，43(2)：310—316．
[14] Long z D，Xu J H，Zhao LL．et a1．Overexpression of Serratiamarcescens lipase in Escherichia coli for efficient bioresolution ofracemic ketoprofen[J]．Journal of MolecularCatalysis B：Enzy—matic．2007.47(3-4)：105—1l0． [15]Wang Y，Hu Y，Xu J，et a1．Immobilization of lipase witha speeialmicrostructure in composite hydrophilie CA／hydrophobie PTFEmembrane for the chiralseparation of racemic ibuprofen[J]．Journal of Membrane Science．2007。293(1-2)：133—141．
[16] Bae H A，Lee K W，Lee Y H．Enantioselective properties of ex—tracellular lipase from Serratia raarce$cens ES-2 for kinetic resolution of(s)一flurbiprofen[J]．Journal of Molecular Catalysis B：Enzymatic，2006，40(1—2)：24-29． [17] Hollmann F，Arends I W C E，Holtmann D．Enzymat—ic reductions for the chemist[J]．Green Chem，2011，13(9)：2285-2314．
[18] Cleij M, Archelas A, Furstoss R. Microbiological transformations 43 epoxide hydrolases as tools for the synthesis of enanatiopure alpha-methylstyrene oxides: a new and efficient synthesis of ( S )-ibuprofen [ J] . Journal of Organic Chemist, 1999, 64( 14) : 5 029~ 5 035.
[19] David H, Howard D, David W, et al. Studies on pyruvate de?carboxylase: acyloin formation from aliphatic, aromatic andheterocyclic aldehydes[ J] . J Chem Soc perkin Trans, 1991,5: 1 329~ 1 334.
[20] 陈海丽,王梦阳.生物催化反应的应用[J]. 河南化工, 2010,27(4).
[21] 陈喜华,刘景晶.血管紧张素转化酶抑制剂与癌症关系的研究进展[J]. 药物生物技术, 2010, (02) :172.
[22] Hanson R, Bembenek K, Patel R, et al. Transformation of N lA-CBZ- l- lysine to CBZ- l- oxylysine using l- amino acid oxidase fromProvidencia alcalifaciens and l- 2- hydroxy- isocaproate dehydrogenasefrom Lactobacillus confusus[J]. Applied Microbiology andBiotechnology, 1992, 37(5):599.
[23] Greenberg W, Varvak A, Hanson S, et al. Development of an efficient,scalable,aldolase- catalyzed process for enantioselectivesynthesis of statin intermediates[J]. Proceedings of the NationalAcademy of Sciences of the United States of America, 2004,101(16):5788.
[24] Genovesi E, Lamb L, Medina I, et al. Efficacy of the carbocyclic2'- deoxyguanosine nucleoside BMS- 200475 in the woodchuckmodel of hepatitis B virus infection[J]. Antimicrobial agents andchemotherapy, 1998, 42(12):3209.
[25] Patel R,Banerjee A,Pendri ,et al. Preparation of a chiralsynthon for an HBV inhibitor:enzymatic asymmetric hydrolysis of(1 ［ alpha］, 2 ［beta］ , 3 ［alpha］ )- 2- (benzyloxymethyl) cyclo-pent-4- ene- 1, 3- diol diacetate and enzymatic asymmetric acetyla-tion of (1 ［alpha］,2 ［beta］, 3 ［alpha］ )- 2- (benzyloxymethyl)cyclopent-4- ene- 1, 3- diol[J]. Tetrahedron:Asymmetry, 2006,17(2):175.